Women: More Prone to Lower Coronary Flow Reserve

Compared to men, women have less chances of developing obstructive coronary artery disease (CAD), but this new study suggests they are more prone to have lower coronary flow reserve, which is also a risk factor.

 

Evidently, ischemic cardiomyopathy entails far more than assessing and treating plaque burden in epicardial arteries. In women, the most prevalent pathological phenotype was low coronary flow reserve in absence of OBSTRUCTIVE CAD, while in men, most of patients presenting low coronary flow reserve had multiple vessels disease. 

 

This study, simultaneously published in Circulation, assessed 329 patients (43% women) referred for a coronary angiography after positive stress test and > 40% ejection fraction.

 

Regardless of their similar age, cardiovascular medication and ischemia extension, women had lower pretest clinical risk, with lower rates of MI and burden of angiographic CAD, compared to men.

 

Moreover, women also presented less obstructive CAD and lower revascularization rate. Despite of traditional scores, women had higher risk of events at 3 years.

 

After adjusting for epicardial disease, women continued to have higher events risk than men (HR 2.05; 95% CI 1.05-4.02).

 

No doubt, we need to better understand the relationship between microvascular dysfunction and comorbidities, such as insulin resistance or cardiac failure.

 

Coronary flow reserve could be an important risk marker, not only for prospective studies assessing the role of ischemia and revascularization, but also as a target for new anti-inflammatory or hypolipidemic drugs, or neurohormone modulators.

 

Original Title: Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease.

Presenter: Taqueti VR.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...